Centres

Studies

As part of the Continence and Pelvic Floor Centre South Baden, we conduct studies, about which we would like to inform you here.

As part of the Continence and Pelvic Floor Centre South Baden, we conduct studies, about which we would like to inform you here.

The CASPO study is a prospective, multicentre, single-arm cohort study. with the following aims:

evaluation of treatment success and
review of the safety of the ultra-lightweight mesh Calistar S for the transvaginal treatment of pelvic floor prolapse.

Who can take part in the study?

Participants with symptomatic anterior prolapse with or without involvement of the apical vaginal wall according to POP-Q score ≥ 2 (corresponds to Aa, Ba ≥ -1 and, if applicable, C ≥ -1/2 TVL)
Participants with recurrent prolapse

Study duration: 60 months

Status: Recruitment completed (new participation not possible)

Further information: Eudamed no.: CIV-18-12-026588, Procedure for using Calistar S